Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In the last ten years FDA made 16 decisions for Kyocera Medical Technologies (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2025 (4). The latest was on 2026-07-15.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 7 |
| Cervical fusion & disc arthroplasty | 3 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-07-15 | 510(k) | K261353 | Tesera-K Anterior Lumbar Interbody Fusion (ALIF) System; Tesera-K XL System; Lumbar Anchor System |
| 2025-04-10 | 510(k) | K242045 | Initia T3 Acetabular Hemispherical Shell System |
| 2025-04-10 | 510(k) | K242928 | Tesera-k SC System |
| 2025-03-20 | 510(k) | K242771 | Tesera-k PL System and Tesera-k XL System |
| 2025-01-13 | 510(k) |
| K243295 |
| Initia Knee System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Kyocera Medical Technologies.